MARISSA ALVERO: Open Payments
NPI 1538834130 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$172 in 9 payments from 5 companies in 2025. Trend: 2023 $191 · 2024 $53 · 2025 $172
Food & beverage: $172
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| GENZYME CORPORATION | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $18 |
Products named: ENTYVIO, DUPIXENT, VOQUEZNA, ZENPEP, IBSRELA.
Industry payments across LA — which companies pay providers there.
